It is a pharma private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2010.
2010 | Visakhapatnam, Andhra Pradesh, India | ActiveNan Pharma Private Limited, a active private limited company, was established on 05 July 2010 in Visakhapatnam, Andhra Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232AP2010PTC069300. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 3 professional, Its leadership includes Appala Narasimha Murthy Nukala (Director), Sundari Anupindi (Director), Surya Venkata Satya Ganti Girija (Director). Past directors included Surya Venkata Satya Ganti Girija, Rajithamba Dabbiru, Bhavana Venkata Nagabhushana Rao. It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Door No.43-9-163, S S Towers T S N Colony, Dondaparthy, Visakhapatnam, Andhra Pradesh, 530016.
U24232AP2010PTC069300
069300
05 July 2010
₹1.00 M
₹0.10 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Nan Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Appala Narasimha Murthy Nukala | Director | 05 Jul 2010 | Current |
| Sundari Anupindi | Director | 05 Jul 2010 | Current |
| Surya Venkata Satya Ganti Girija | Director | 16 Jun 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 20 Sep 2014 | Past |
| Pramod Abcsdd | Director | 14 Nov 2018 | Past |
| Pramod Abcsdd | Director | 16 Jun 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nan Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.72% increase. The company also saw a substantial improvement in profitability, with a 184.4% increase in profit. The company's net worth moved up by a moderate rise of 3.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Nan Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Sep 2012 | The Karnataka Bank Limited | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nan Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nan Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
The activity Nan Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Vijayawada. was completed.
Surya Venkata Satya Ganti Girija was appointed as a Director was appointed as a Director on 16 Jun 2014 & has been associated with this company since 11 years 5 months . was recorded as a recent event.
Progress on A charge with The Karnataka Bank Limited amounted to Rs. 1.00 M with Charge ID 10383562 was registered on 21 Sep 2012. was documented.
Appala Narasimha Murthy Nukala was appointed as a Director was appointed as a Director on 05 Jul 2010 & has been associated with this company since 15 years 4 months . was recorded as a recent event.
The activity Sundari Anupindi was appointed as a Director was appointed as a Director on 05 Jul 2010 & has been associated with this company since 15 years 4 months . was completed.
The CIN of Nan Pharma Private Limited is U24232AP2010PTC069300.
Nan Pharma Private Limited is headquartered at Door No.43-9-163, S S Towers T S N Colony, Dondaparthy, Visakhapatnam, Andhra Pradesh, 530016.
Nan Pharma Private Limited was incorporated on 05 July 2010.
The current directors of Nan Pharma Private Limited are
The primary industry of Nan Pharma Private Limited is Trade.
Nan Pharma Private Limited is unlisted.
The authorized capital of Nan Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Nan Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX